| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zenas Biopharma, Inc. (ZBIO) has 12 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. ZBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.21M | $45.11M | - | |
| 10% | 1.17M | $23.96M | - | |
| Other | 500.0K | $10.21M | - | |
| Other | 175.0K | $3.57M | - | |
| Other | 150.0K | $3.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Moulder Leon O Jr79 | Chief Executive Officer | Buy | 25,000 | $6.67 | $166,750.00 | +10.4% | +65.6% | +301.2% | |
| Feb 7, 2025 | Xiao Ting | Director | Buy | 10,000 | $7.76 | $77,600.00 | +27.0% | +20.5% | +182.7% | |
| Dec 4, 2024 | Moulder Leon O Jr79 | Chief Executive Officer | Buy | 70,000 | $10.26 | $718,100.00 | +19.1% | -29.6% | +287.3% | |
| Nov 19, 2024 | Moulder Leon O Jr79 | Chief Executive Officer | Buy | 10,000 | $14.89 | $148,925.00 | +3.0% | -54.1% | +156.2% | |
| Sep 20, 2024 | Moulder Leon O Jr79 | Chief Executive Officer | Buy | 20,000 | $18.04 | $360,819.97 | +0.3% | -48.6% | -0.3% | |
| Sep 16, 2024 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 2,235,294 | $17.00 | $37,999,998.00 | +83.5% | -51.2% | +1.5% | |
| Sep 16, 2024 | Enavate Sciences Gp, LLC | 10% Owner | Buy | 882,353 | $17.00 | $15,000,001.00 | +30.6% | -51.2% | +1.5% | |
| Sep 16, 2024 | Nunn Jason Raleigh | Director | Buy | 882,352 | $17.00 | $14,999,984.00 | +40.6% | -51.2% | +1.5% | |
| Sep 16, 2024 | Fairmount Funds Management LLC73 | Director | Buy | 300,000 | $17.00 | $5,100,000.00 | +23.0% | -51.2% | +1.5% | |
| Sep 16, 2024 | Enright Patrick G74 | Director | Buy | 440,000 | $17.00 | $7,480,000.00 | +131.5% | -51.2% | +1.5% |